CD4 and cancer: They apply TIMER to the inference of six distinct immune subsets (B cells, CD4 T cells, CD8 T cells, neutrophils, macrophages, and dendritic cells) in The Cancer Genome Atlas (TCGA) bulk tumor expression profiles and investigate links between TIL heterogeneity, tumor genomic features, and survival in 23 cancer types.